Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the
Year of publication
2022
Authors
Kolonen A; Sinisalo M; Huhtala H; Rimpiläinen J; Rintala H; Sankelo M; Koivunen E; Silvennoinen R; Räty R; Ruutu T; Volin L; Porkka K; Jantunen E; Nousiainen T; Kuittinen T; Penttilä K; Pyörälä M; Säily M; Koistinen P; Kauppila M; Itälä-Remes M
Organizations and authors
Turku University Central Hospital
Ollikainen Hanna
Itälä-Remes Maija
Kauppila Marjut
Rauhala Auvo
Kairisto Veli
Oulu University Hospital
Säily Marjaana
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Volume
109
Issue
3
Pages
257-270
ISSN
Publication forum
Publication forum level
1
Open access
Open access in the publisher’s service
No
Self-archived
No
Other information
Fields of science
General medicine, internal medicine and other clinical medicine
Internationality of the publisher
International
International co-publication
No
Co-publication with a company
Yes
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes